Tokyo, April 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060862) titled 'Effect of Quantity of Blood flow in Arteriovenous Fistula for Hemodialysis on Right Heart Load Findings' on April 20.
Study Type:
Observational
Primary Sponsor:
Institute - Saitama Medical University
Condition:
Condition - Congestive heart failure in hemodialysis patients
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effect of quantity of blood flow (QB) through arteriovenous fistulas (AVFs) for hemodialysis on the development of congestive heart failure and findings of right ventricular overload, and to re-examine the risk of heart failure associated with QB of AVFs.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Cases undergoing continuous hemodialysis management at our hospital during the period from April 1, 2020, to March 31, 2025
Key exclusion criteria - 1) Cases not maintaining an AVF as vascular access
2) Cases where follow-up could not be confirmed due to death or failure to attend follow-up appointments
3) Other individuals deemed ineligible by the physician's judgment
Target Size - 100
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 04 Month 20 Day
Anticipated trial start date - 2026 Year 04 Month 20 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069643
Disclaimer: Curated by HT Syndication.
